Pasar al contenido principal

CONDENSADOS SINTETICOS BASADOS EN PROTEINAS DEL TIPO ELASTINA PARA APLICACIONES BIOTECNOLOGICAS Y BIOMEDICAS

PID2022-137484OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cholesterol Conjugated Elastin-like Recombinamers: Molecular Dynamics Simulations, Conformational Changes, and Bioactivity

  • Costa, Rui R.
  • Domínguez-Arca, Vicente
  • Velasco, Brenda
  • Reis, Rui L.
  • Rodríguez-Cabello, José Carlos
  • Pashkuleva, Iva
  • Taboada, Pablo
  • Prieto, Gerardo
14 pages, 8 figures, 2 tables, Current models for elastin-like recombinamer (ELR) design struggle to predict the effects of nonprotein fused materials on polypeptide conformation and temperature-responsive properties. To address this shortage, we investigated the novel functionalization of ELRs with cholesterol (CTA). We employed GROMACS computational molecular dynamic simulations complemented with experimental evidence to validate the in silico predictions. The ELRCTA was biosynthesized and characterized by using fluorescence assays, circular dichroism, dynamic light scattering, and differential scanning calorimetry. The in silico and in vitro data showed that CTA promotes the formation of intramolecular hydrogen bonds that favor β-sheet secondary structures. Compared with an unmodified ELRVKV, CTA enhanced the hydrophobicity and stability of the system, allowing the formation of monodisperse nanoaggregates at physiologically relevant temperatures. Importantly, calorimetry assays revealed that ELRCTA interacted and intercalated with the lipid bilayers of the DPPC liposomes. To demonstrate the implications of these changes for biomedical applications, ELRCTA and DPPC-ELRCTA hybrid nanoparticles were tested with cancer and immune cell lines. Interactions with the cell membranes demonstrated a synergistic effect of the composition and size of the modified recombinamer aggregates on the internalization. The results indicated the potential use of ELR-based nanoparticles for localized and systemic drug delivery. This work sets a new precedent to design elastin-inspired biomaterials with predictable self-assembly properties and develop novel drug delivery strategies, This work was supported by the Fundação para a Ciência e Tecnologia (project OncoNeoTreat, grant number PTDC/CTM-REF/0022/2020, cofinanced by FCT–OE component, DOI: 10.54499/PTDC/CTM-REF/0022/2020). R.R.C. acknowledges the IACOBUS Programme for the travel grant and FCT for financial support through grants 2022.00764.CEECIND/CP1718/CT0020 (DOI: 10.54499/2022.00764.CEECIND/CP1718/CT0020) and CEECIND/02842/2017/CP1458/CT0025 (DOI: 10.54499/CEECIND/02842/2017/CP1458/CT0025). J.C.R.C. is grateful for funding from the Spanish Government (PID2022-137484OB-I00), Junta de Castilla y León (VA188P23), and Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León. P.T. and G.P. thank the Agencia Estatal de Investigación (AEI) for funding through project PID2022-142682OB-I00 and Xunta de Galicia for grant ED431C 2022/28. ERDF funds are also acknowledged, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Injectable elastin-like recombinamer hydrogels with layered degradation rates for osteochondral regeneration in a rabbit model

  • Venegas-Bustos, Desiré
  • Martínez-Municio, Gonzalo
  • Martínez-Páramo, S.
  • González de Torre, Israel
  • Lamus, F.
  • Alonso, M. I.
  • Gato, A.
  • Álvarez-Barcia, A. J.
  • Vega-Castrillo, A.
  • Alberca, Mercedes
  • Rodriguez-Cabello, Jose Carlos
The regeneration of osteochondral defects remains a significant challenge due to the distinct structural and functional requirements of cartilage and subchondral bone. Current strategies often employ multiphasic scaffolds to mimic the complex osteochondral unit. In this study, we developed an injectable hydrogel system with inner and outer layers exhibiting distinct degradation rates and cell combinations, designed to regenerate critical-sized osteochondral defects in a long-term rabbit model. The hydrogel system is based on elastin-like recombinamers (ELRs), which promote cell adhesion, proliferation, and mechanical integrity. Bioactive sequences, including RGD for cell adhesion and proteolytic motifs with different degradation kinetics, slow-cleaving (DRIR) and fast-cleaving (GTAR), were incorporated into the design. These hydrogels are delivered in liquid form, solidifying in situ to conform to osteochondral defects. To explore the role of cellular interactions, mesenchymal stem cells (MSCs) and chondrocytes were incorporated into the hydrogels. After six months in vivo, outcomes were evaluated via glycosaminoglycan quantification, histological, and immunohistochemistry analyses, revealing cartilage-like tissue production. Statistical analysis using a modified O’Driscoll score demonstrated significant differences (p < 0.05) between homogeneous hydrogels (with either fast or slow degradation rates) and both the untreated control and the chondrocyte-only condition. No significant differences were found among other experimental groups based on the O’Driscoll score; however, histological analysis confirmed promising cartilage-like tissue formation, even in the cell-free hydrogel condition. These findings highlight the potential of in situ crosslinkable ELR hydrogels as a versatile and effective strategy for osteochondral repair, demonstrating substantial cartilage-like tissue formation, even without cellular components. Moreover, the incorporation of MSCs—likely through paracrine signaling—significantly enhanced overall regenerative outcomes, offering a promising stem cell–based approach for treating osteochondral lesions., The authors are grateful for funding from the Spanish Government (grants PID2021‐122444OB‐100 and PID2022‐137484OB‐I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF, EU), from the Department of Education, Junta de Castilla y León (grant VA188P23 and CLU-2023–1–05 cofunded by ERDF) and from Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León., Peer reviewed